A$283.46
0.67% yesterday
Australia, Oct 03, 08:10 am CET
ISIN
AU000000COH5
Symbol
COH

Cochlear Target price 2025 - Analyst rating & recommendation

Cochlear Classifications & Recommendation:

Buy
37%
Hold
53%
Sell
11%

Cochlear Price Target

Target Price A$303.67
Price A$283.46
Potential
Number of Estimates 17
17 Analysts have issued a price target Cochlear 2026 . The average Cochlear target price is A$303.67. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 19 analysts: 7 Analysts recommend Cochlear to buy, 10 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Cochlear stock has an average upside potential 2026 of . Most analysts recommend the Cochlear stock at Hold.

Sales and Margin forecast 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Jun '25 2026
Estimates
Revenue Billion A$ 2.34 2.62
4.81% 11.90%
Net Margin 16.60% 17.40%
4.00% 4.83%

18 Analysts have issued a sales forecast Cochlear 2026 . The average Cochlear sales estimate is

A$2.6b
Unlock
. This is
11.90% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
A$2.9b 22.66%
Unlock
, the lowest is
A$2.4b 3.67%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 A$2.3b 4.81%
2026
A$2.6b 11.90%
Unlock
2027
A$2.9b 11.63%
Unlock
2028
A$3.2b 10.80%
Unlock
2029
A$3.5b 9.16%
Unlock
2030
A$3.7b 4.35%
Unlock
2031
A$3.9b 5.39%
Unlock
2032
A$4.2b 8.66%
Unlock

17 Cochlear Analysts have issued a net profit forecast 2026. The average Cochlear net profit estimate is

A$456m
Unlock
. This is
17.30% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
A$501m 28.94%
Unlock
, the lowest is
A$426m 9.56%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 A$389m 9.00%
2026
A$456m 17.30%
Unlock
2027
A$523m 14.71%
Unlock
2028
A$591m 13.04%
Unlock
2029
A$674m 13.92%
Unlock
2030
A$733m 8.76%
Unlock
2031
A$746m 1.77%
Unlock
2032
A$814m 9.07%
Unlock

Net Margin

2025 16.60% 4.00%
2026
17.40% 4.83%
Unlock
2027
17.88% 2.76%
Unlock
2028
18.24% 2.01%
Unlock
2029
19.04% 4.39%
Unlock
2030
19.84% 4.20%
Unlock
2031
19.16% 3.43%
Unlock
2032
19.23% 0.37%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Jun '25 2026
Estimates
Earnings Per Share A$ 5.93 6.98
9.21% 17.71%
P/E 40.64
EV/Sales 7.01

17 Analysts have issued a Cochlear forecast for earnings per share. The average Cochlear EPS is

A$6.98
Unlock
. This is
17.71% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
A$7.67 29.34%
Unlock
, the lowest is
A$6.52 9.95%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 A$5.93 9.21%
2026
A$6.98 17.71%
Unlock
2027
A$8.00 14.61%
Unlock
2028
A$9.04 13.00%
Unlock
2029
A$10.30 13.94%
Unlock
2030
A$11.21 8.83%
Unlock
2031
A$11.41 1.78%
Unlock
2032
A$12.44 9.03%
Unlock

P/E ratio

Current 47.80 7.02%
2026
40.64 14.98%
Unlock
2027
35.43 12.82%
Unlock
2028
31.34 11.54%
Unlock
2029
27.51 12.22%
Unlock
2030
25.29 8.07%
Unlock
2031
24.85 1.74%
Unlock
2032
22.79 8.29%
Unlock

Based on analysts' sales estimates for 2026, the Cochlear stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 7.84 3.45%
2026
7.01 10.62%
Unlock
2027
6.28 10.42%
Unlock
2028
5.67 9.74%
Unlock
2029
5.19 8.39%
Unlock
2030
4.97 4.17%
Unlock
2031
4.72 5.11%
Unlock
2032
4.34 7.97%
Unlock

P/S ratio

Current 7.86 4.67%
2026
7.02 10.64%
Unlock
2027
6.29 10.42%
Unlock
2028
5.68 9.75%
Unlock
2029
5.20 8.39%
Unlock
2030
4.98 4.17%
Unlock
2031
4.73 5.11%
Unlock
2032
4.35 7.97%
Unlock

Current Cochlear Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JEFFERIES
Locked
Locked
Locked Sep 08 2025
MACQUARIE RESEARCH
Locked
Locked
Locked Aug 21 2025
JEFFERIES
Locked
Locked
Locked Jul 17 2025
JEFFERIES
Locked
Locked
Locked Jul 16 2025
MACQUARIE RESEARCH
Locked
Locked
Locked Jul 16 2025
MACQUARIE RESEARCH
Locked
Locked
Locked Jul 15 2025
JEFFERIES
Locked
Locked
Locked Apr 08 2025
Analyst Rating Date
Locked
JEFFERIES:
Locked
Locked
Sep 08 2025
Locked
MACQUARIE RESEARCH:
Locked
Locked
Aug 21 2025
Locked
JEFFERIES:
Locked
Locked
Jul 17 2025
Locked
JEFFERIES:
Locked
Locked
Jul 16 2025
Locked
MACQUARIE RESEARCH:
Locked
Locked
Jul 16 2025
Locked
MACQUARIE RESEARCH:
Locked
Locked
Jul 15 2025
Locked
JEFFERIES:
Locked
Locked
Apr 08 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today